Title : Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis.

Pub. Date : 2020 Jan

PMID : 31634532






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Farnesoid X receptor (FXR) agonist, obeticholic acid (OCA), increases total and low-density lipoprotein cholesterol (LDL-C) in patients with nonalcoholic steatohepatitis (NASH). obeticholic acid xenotropic and polytropic retrovirus receptor 1 Homo sapiens
2 BACKGROUND: Farnesoid X receptor (FXR) agonist, obeticholic acid (OCA), increases total and low-density lipoprotein cholesterol (LDL-C) in patients with nonalcoholic steatohepatitis (NASH). obeticholic acid xenotropic and polytropic retrovirus receptor 1 Homo sapiens
3 Recently, obeticholic acid (OCA), a farnesoid X receptor agonist, improved liver disease but led to an increase in cholesterol, however, the impact of OCA on cholesterol is not well understood. obeticholic acid xenotropic and polytropic retrovirus receptor 1 Homo sapiens
4 Recently, obeticholic acid (OCA), a farnesoid X receptor agonist, improved liver disease but led to an increase in cholesterol, however, the impact of OCA on cholesterol is not well understood. obeticholic acid xenotropic and polytropic retrovirus receptor 1 Homo sapiens